Targeted drug delivery: Binding and uptake of plant lectins using human 5637 bladder cancer cells

被引:46
|
作者
Plattner, Verena E. [1 ]
Wagner, Maria [1 ]
Ratzinger, Gerda [1 ]
Gabor, Franz [1 ]
Wirth, Michael [1 ]
机构
[1] Univ Vienna, Fac Life Sci, Dept Pharmaceut Technol & Biopharmaceut, A-1090 Vienna, Austria
关键词
Bladder; 5637; cells; Lectins; Bioadhesion; Drug targeting;
D O I
10.1016/j.ejpb.2008.06.004
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In an effort to detect novel strategies in bladder cancer therapy, the potential and the applicability of different plant lectins was investigated using 5637 cells as a model for human urinary carcinoma. The cell-lectin interaction studies were performed with single cells as well as monolayers using flow cytometry and fluorimetry. As a result, wheat germ agglutinin (WGA) and Ulex europaeus agglutinin (UEA) revealed strongest interaction with single cells demonstrating a high presence of N-acetyl-D-glucosamine, sialic acid and alpha-L-fucose residues on the membrane surface. Considering monolayers, binding of most lectins depended on the culturing period pointing to a change in the glycocalyx composition during Cultivation. However, constant binding capacities combined with a high specificity were detected for WGA. Cytoinvasion studies were performed with WGA and revealed a decreased fluorescence intensity at 37 degrees C as compared to 4 degrees C, which points to internalisation of the lectin and accumulation in acidic compartments. Intracellular localization was confirmed by addition of monensin that compensates the pH-gradient between acidic compartments and cytoplasm leading to a full reversal of the decline in fluorescence. According to these findings, some lectins, especially WGA, offer promising features for targeting drugs to bladder cancer cells. This might be interesting for the development of functionalized drug delivery systems for site specific antitumor therapy leading to reduced toxicity, prolonged exposition, and improved efficacy. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:572 / 576
页数:5
相关论文
共 50 条
  • [1] Binding and internalization of plant lectins in conjunctival epithelial cells: Potential for ocular drug delivery
    Qaddoumi, MG
    Lee, VHL
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2003, 44 : U322 - U322
  • [2] Binding and uptake of plant lectins by Caco-2 cells
    Lehr, CM
    Haltner, E
    FASEB JOURNAL, 1997, 11 (03): : 2449 - 2449
  • [3] Targeted drug delivery systems for bladder cancer therapy
    Yu, Kun
    Liu, Meiping
    Dai, Hong
    Huang, Xiao
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2020, 56
  • [4] Targeted drug delivery to cancer cells using synthetic bacteria
    Kong, Minsuk
    Ramamurthi, Kumaran
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 256
  • [5] Targeted drug delivery: Understanding cellular binding and uptake of nanoengineered capsules
    Johnston, Angus P. R.
    Such, Georgina K.
    Kamphuis, Marloes
    Caruso, Frank
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 244
  • [6] Tunable immunonanoparticle binding to cancer cells: thermodynamic analysis of targeted drug delivery vehicles
    Ho, Karyn
    Lapitsky, Yakov
    Shi, Meng
    Shoichet, Molly S.
    SOFT MATTER, 2009, 5 (05) : 1074 - 1080
  • [7] Amphiphilic Janus dendrimer for targeted-drug delivery to human cancer cells
    Castillo-Rodriguez, Irving Osiel
    Hernandez-Rioja, Isabel
    Barajas-Mendoza, Israel
    Saavedra-Gonzalez, Ilse
    Ramirez-Apan, Teresa
    Martinez-Garcia, Marcos
    TETRAHEDRON, 2024, 165
  • [8] Thymoquinone enhanced the antitumor activity of cisplatin in human bladder cancer 5637 cells in vitro
    Fatemeh Khodadadi
    Mohsen Khorashadizadeh
    Fahimeh Ghasemi
    Molecular Biology Reports, 2023, 50 : 5767 - 5775
  • [9] Thymoquinone enhanced the antitumor activity of cisplatin in human bladder cancer 5637 cells in vitro
    Khodadadi, Fatemeh
    Khorashadizadeh, Mohsen
    Ghasemi, Fahimeh
    MOLECULAR BIOLOGY REPORTS, 2023, 50 (07) : 5767 - 5775
  • [10] HEAT-TARGETED DRUG DELIVERY USING THE COMBAT BRS DEVICE FOR TREATING BLADDER CANCER
    Brousell, Steven C.
    Longo, Thomas A.
    Fantony, Joseph J.
    Etienne, Wiguins
    Needham, David
    Dewhirst, Mark W.
    Maccarini, Paolo F.
    Spasojevic, Ivan
    Inman, Brant A.
    JOURNAL OF UROLOGY, 2017, 197 (04): : E855 - E855